{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CORT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:52:49.602Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9133,"canonical_name":"CORCEPT THERAPEUTICS INC","cik":"0001088856","uei":null,"lei":null,"duns":null,"ticker":"CORT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":162,"clinical":5},"count":100,"timeline":[{"ts":"2026-10-16","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-10-16","url_slug":"/sec/cik-0001088856/4/0001193125-26-424350","accession_number":"0001193125-26-424350","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"3","title":"3 — CORCEPT THERAPEUTICS INC — 2026-10-05","url_slug":"/sec/cik-0001088856/3/0001193125-26-414633","accession_number":"0001193125-26-414633","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-10-05","url_slug":"/sec/cik-0001088856/4/0001193125-26-414667","accession_number":"0001193125-26-414667","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-10-05","url_slug":"/sec/cik-0001088856/4/0001193125-26-414674","accession_number":"0001193125-26-414674","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-10-05","url_slug":"/sec/cik-0001088856/4/0001193125-26-414684","accession_number":"0001193125-26-414684","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-10-05","url_slug":"/sec/cik-0001088856/4/0001193125-26-414688","accession_number":"0001193125-26-414688","importance":30},{"ts":"2026-10-02","kind":"sec.insider.5147","reporter":"Vieira Roberto Wandenkolk","title":"President, Oncology","shares":5147,"price_per_share":116.585,"usd_value":600063,"security_title":"Common Stock","importance":15.600062995},{"ts":"2026-10-02","kind":"sec.insider.2086","reporter":"Vieira Roberto Wandenkolk","title":"President, Oncology","shares":2086,"price_per_share":115.7298,"usd_value":241412,"security_title":"Common Stock","importance":15.2414123628},{"ts":"2026-10-02","kind":"sec.insider.8333","reporter":"Vieira Roberto Wandenkolk","title":"President, Oncology","shares":8333,"price_per_share":21.63,"usd_value":180243,"security_title":"Common Stock","importance":15.18024279},{"ts":"2026-10-02","kind":"sec.insider.1100","reporter":"Vieira Roberto Wandenkolk","title":"President, Oncology","shares":1100,"price_per_share":114.5205,"usd_value":125973,"security_title":"Common Stock","importance":15.12597255},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-10-01","url_slug":"/sec/cik-0001088856/144/0001973251-26-000038","accession_number":"0001973251-26-000038","importance":30},{"ts":"2026-09-28","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-28","url_slug":"/sec/cik-0001088856/4/0001193125-26-405402","accession_number":"0001193125-26-405402","importance":30},{"ts":"2026-09-23","kind":"sec.filing","form_type":"8-K","title":"8-K — CORCEPT THERAPEUTICS INC — 2026-09-23","url_slug":"/sec/cik-0001088856/8-k/0001193125-26-398561","accession_number":"0001193125-26-398561","importance":35},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-18","url_slug":"/sec/cik-0001088856/4/0001193125-26-395827","accession_number":"0001193125-26-395827","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-18","url_slug":"/sec/cik-0001088856/4/0001193125-26-395837","accession_number":"0001193125-26-395837","importance":30},{"ts":"2026-09-17","kind":"sec.insider.17493","reporter":"Robb Gary Charles","title":"Chief Business Officer","shares":17493,"price_per_share":8.27,"usd_value":144667,"security_title":"Common Stock","importance":15.14466711},{"ts":"2026-09-16","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-16","url_slug":"/sec/cik-0001088856/4/0001193125-26-393124","accession_number":"0001193125-26-393124","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-16","url_slug":"/sec/cik-0001088856/4/0001193125-26-393125","accession_number":"0001193125-26-393125","importance":30},{"ts":"2026-09-16","kind":"sec.insider.296","reporter":"Vieira Roberto Wandenkolk","title":"President, Oncology","shares":296,"price_per_share":100.82,"usd_value":29843,"security_title":"Common Stock","importance":15.02984272},{"ts":"2026-09-15","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-09-15","url_slug":"/sec/cik-0001088856/144/0001949846-26-000585","accession_number":"0001949846-26-000585","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-09-14","url_slug":"/sec/cik-0001088856/144/0001973251-26-000037","accession_number":"0001973251-26-000037","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"3","title":"3 — CORCEPT THERAPEUTICS INC — 2026-09-03","url_slug":"/sec/cik-0001088856/3/0001193125-26-382432","accession_number":"0001193125-26-382432","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-03","url_slug":"/sec/cik-0001088856/4/0001193125-26-382450","accession_number":"0001193125-26-382450","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-03","url_slug":"/sec/cik-0001088856/4/0001193125-26-382456","accession_number":"0001193125-26-382456","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-03","url_slug":"/sec/cik-0001088856/4/0001193125-26-382457","accession_number":"0001193125-26-382457","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-03","url_slug":"/sec/cik-0001088856/4/0001193125-26-382463","accession_number":"0001193125-26-382463","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-03","url_slug":"/sec/cik-0001088856/4/0001193125-26-382474","accession_number":"0001193125-26-382474","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-09-03","url_slug":"/sec/cik-0001088856/4/0001193125-26-382475","accession_number":"0001193125-26-382475","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-09-02","url_slug":"/sec/cik-0001088856/144/0001972481-26-000271","accession_number":"0001972481-26-000271","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-28","url_slug":"/sec/cik-0001088856/4/0001193125-26-374607","accession_number":"0001193125-26-374607","importance":30},{"ts":"2026-08-27","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-27","url_slug":"/sec/cik-0001088856/4/0001193125-26-371388","accession_number":"0001193125-26-371388","importance":30},{"ts":"2026-08-26","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-08-26","url_slug":"/sec/cik-0001088856/144/0001950047-26-008710","accession_number":"0001950047-26-008710","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-08-25","url_slug":"/sec/cik-0001088856/144/0001972481-26-000268","accession_number":"0001972481-26-000268","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-20","url_slug":"/sec/cik-0001088856/4/0001193125-26-359255","accession_number":"0001193125-26-359255","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-08-18","url_slug":"/sec/cik-0001088856/144/0001949846-26-000521","accession_number":"0001949846-26-000521","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-18","url_slug":"/sec/cik-0001088856/4/0001193125-26-355560","accession_number":"0001193125-26-355560","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-18","url_slug":"/sec/cik-0001088856/4/0001193125-26-355562","accession_number":"0001193125-26-355562","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-18","url_slug":"/sec/cik-0001088856/4/0001193125-26-355563","accession_number":"0001193125-26-355563","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-08-17","url_slug":"/sec/cik-0001088856/144/0001972481-26-000262","accession_number":"0001972481-26-000262","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-14","url_slug":"/sec/cik-0001088856/4/0001193125-26-352428","accession_number":"0001193125-26-352428","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-12","url_slug":"/sec/cik-0001088856/4/0001193125-26-346942","accession_number":"0001193125-26-346942","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-12","url_slug":"/sec/cik-0001088856/4/0001193125-26-346951","accession_number":"0001193125-26-346951","importance":30},{"ts":"2026-08-12","kind":"sec.insider.g","reporter":"Robb Gary Charles","title":"Chief Business Officer","shares":11530,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-12","kind":"sec.insider.g","reporter":"Robb Gary Charles","title":"Chief Business Officer","shares":3000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-12","kind":"sec.insider.g","reporter":"Robb Gary Charles","title":"Chief Business Officer","shares":3000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Guyer William","title":"Chief Development Officer","shares":11530,"price_per_share":113.1772,"usd_value":1304933,"security_title":"Common Stock","importance":36.304933116},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Guyer William","title":"Chief Development Officer","shares":4770,"price_per_share":114.0371,"usd_value":543957,"security_title":"Common Stock","importance":35.543956967},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Maduck Sean","title":"See Remarks","shares":1031,"price_per_share":114.5182,"usd_value":118068,"security_title":"Common Stock","importance":35.1180682642},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"Guyer William","title":"Chief Development Officer","shares":16300,"price_per_share":21.65,"usd_value":352895,"security_title":"Common Stock","importance":15.352895},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"Maduck Sean","title":"See Remarks","shares":1031,"price_per_share":8.27,"usd_value":8526,"security_title":"Common Stock","importance":15.00852637},{"ts":"2026-08-06","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-06","url_slug":"/sec/cik-0001088856/4/0001193125-26-338637","accession_number":"0001193125-26-338637","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-05","url_slug":"/sec/cik-0001088856/4/0001193125-26-335605","accession_number":"0001193125-26-335605","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-05","url_slug":"/sec/cik-0001088856/4/0001193125-26-335617","accession_number":"0001193125-26-335617","importance":30},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"Guyer William","title":"Chief Development Officer","shares":3700,"price_per_share":113.1248,"usd_value":418562,"security_title":"Common Stock","importance":35.41856176},{"ts":"2026-08-04","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-08-04","url_slug":"/sec/cik-0001088856/144/0001973251-26-000030","accession_number":"0001973251-26-000030","importance":30},{"ts":"2026-08-04","kind":"sec.insider.m","reporter":"Guyer William","title":"Chief Development Officer","shares":3700,"price_per_share":21.65,"usd_value":80105,"security_title":"Common Stock","importance":15.080105},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Maduck Sean","title":"See Remarks","shares":20305,"price_per_share":114.7045,"usd_value":2329075,"security_title":"Common Stock","importance":37.3290748725},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Lyon Joseph Douglas","title":"See Remarks","shares":1540,"price_per_share":114.16,"usd_value":175806,"security_title":"Common Stock","importance":35.1758064},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-08-03","url_slug":"/sec/cik-0001088856/144/0001973251-26-000029","accession_number":"0001973251-26-000029","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-08-03","url_slug":"/sec/cik-0001088856/4/0001193125-26-330668","accession_number":"0001193125-26-330668","importance":30},{"ts":"2026-08-03","kind":"sec.insider.m","reporter":"Maduck Sean","title":"See Remarks","shares":20305,"price_per_share":8.27,"usd_value":167922,"security_title":"Common Stock","importance":15.16792235},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":15477,"price_per_share":114.9601,"usd_value":1779237,"security_title":"Common Stock","importance":36.7792374677},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":14222,"price_per_share":115.8669,"usd_value":1647859,"security_title":"Common Stock","importance":36.6478590518},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":8267,"price_per_share":117.9329,"usd_value":974951,"security_title":"Common Stock","importance":35.9749512843},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":8103,"price_per_share":119.9481,"usd_value":971939,"security_title":"Common Stock","importance":35.9719394543},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":8956,"price_per_share":106.9553,"usd_value":957892,"security_title":"Common Stock","importance":35.9578916668},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":7089,"price_per_share":116.9561,"usd_value":829102,"security_title":"Common Stock","importance":35.8291017929},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":4783,"price_per_share":118.7346,"usd_value":567908,"security_title":"Common Stock","importance":35.5679075918},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":4700,"price_per_share":113.1789,"usd_value":531941,"security_title":"Common Stock","importance":35.531940829999996},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":4200,"price_per_share":105.5352,"usd_value":443248,"security_title":"Common Stock","importance":35.44324784},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":2202,"price_per_share":110.0283,"usd_value":242282,"security_title":"Common Stock","importance":35.2422823166},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":1001,"price_per_share":120.6749,"usd_value":120796,"security_title":"Common Stock","importance":35.1207955749},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":600,"price_per_share":110.95,"usd_value":66570,"security_title":"Common Stock","importance":35.06657},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":400,"price_per_share":108.46,"usd_value":43384,"security_title":"Common Stock","importance":35.043384},{"ts":"2026-07-30","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-07-30","url_slug":"/sec/cik-0001088856/144/0001972481-26-000239","accession_number":"0001972481-26-000239","importance":30},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":80000,"price_per_share":23.06,"usd_value":1844800,"security_title":"Common Stock","importance":16.8448},{"ts":"2026-07-29","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CORCEPT THERAPEUTICS INC — 2026-07-29","url_slug":"/sec/cik-0001088856/10-q/0001628280-26-050613","accession_number":"0001628280-26-050613","importance":45},{"ts":"2026-07-29","kind":"sec.filing","form_type":"8-K","title":"8-K — CORCEPT THERAPEUTICS INC — 2026-07-29","url_slug":"/sec/cik-0001088856/8-k/0001628280-26-050607","accession_number":"0001628280-26-050607","importance":35},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-07-17","url_slug":"/sec/cik-0001088856/4/0001193125-26-308058","accession_number":"0001193125-26-308058","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-07-17","url_slug":"/sec/cik-0001088856/4/0001193125-26-308061","accession_number":"0001193125-26-308061","importance":30},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":28460,"price_per_share":87.8863,"usd_value":2501244,"security_title":"Common Stock","importance":37.501244098},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":7919,"price_per_share":86.776,"usd_value":687179,"security_title":"Common Stock","importance":35.687179144},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"WILSON JAMES N","title":null,"shares":3969,"price_per_share":87.7356,"usd_value":348223,"security_title":"Common Stock","importance":35.3482225964},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":3520,"price_per_share":88.3016,"usd_value":310822,"security_title":"Common Stock","importance":35.310821632},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"WILSON JAMES N","title":null,"shares":2974,"price_per_share":88.8105,"usd_value":264122,"security_title":"Common Stock","importance":35.264122427},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"WILSON JAMES N","title":null,"shares":1978,"price_per_share":89.4881,"usd_value":177007,"security_title":"Common Stock","importance":35.1770074618},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"WILSON JAMES N","title":null,"shares":1079,"price_per_share":86.7777,"usd_value":93633,"security_title":"Common Stock","importance":35.0936331383},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":101,"price_per_share":89.4282,"usd_value":9032,"security_title":"Common Stock","importance":35.0090322482},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":24167,"price_per_share":23.06,"usd_value":557291,"security_title":"Common Stock","importance":15.55729102},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Mokari Atabak","title":"Chief Financial Officer","shares":15833,"price_per_share":19.26,"usd_value":304944,"security_title":"Common Stock","importance":15.30494358},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-07-08","url_slug":"/sec/cik-0001088856/4/0001193125-26-298865","accession_number":"0001193125-26-298865","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — CORCEPT THERAPEUTICS INC — 2026-07-08","url_slug":"/sec/cik-0001088856/4/0001193125-26-298871","accession_number":"0001193125-26-298871","importance":30},{"ts":"2026-07-07","kind":"sec.form144","reporter":"Guyer William","title":"Officer","shares":20000,"usd_value":1862530,"security_title":"Common","approx_sale_date":"2026-07-07","accession_number":"0001973251-26-000028","importance":40.372506},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Guyer William","title":"Chief Development Officer","shares":19048,"price_per_share":93.1059,"usd_value":1773481,"security_title":"Common Stock","importance":36.7734811832},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Guyer William","title":"Chief Development Officer","shares":952,"price_per_share":93.5383,"usd_value":89048,"security_title":"Common Stock","importance":35.0890484616},{"ts":"2026-07-07","kind":"sec.filing","form_type":"144","title":"144 — CORCEPT THERAPEUTICS INC — 2026-07-07","url_slug":"/sec/cik-0001088856/144/0001973251-26-000028","accession_number":"0001973251-26-000028","importance":30},{"ts":"2026-07-07","kind":"sec.insider.19048","reporter":"Guyer William","title":"Chief Development Officer","shares":19048,"price_per_share":93.1059,"usd_value":1773481,"security_title":"Common Stock","importance":16.7734811832},{"ts":"2026-07-07","kind":"sec.insider.20000","reporter":"Guyer William","title":"Chief Development Officer","shares":20000,"price_per_share":21.65,"usd_value":433000,"security_title":"Common Stock","importance":15.433},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Guyer William","title":"Chief Development Officer","shares":20000,"price_per_share":21.65,"usd_value":433000,"security_title":"Common Stock","importance":15.433},{"ts":"2026-07-07","kind":"sec.insider.952","reporter":"Guyer William","title":"Chief Development Officer","shares":952,"price_per_share":93.5383,"usd_value":89048,"security_title":"Common Stock","importance":15.0890484616}]}